MTOR and lymphoma: Shi et al. provided evidence of the ex vivo activity of metformin acting on human lymphoma cells, demonstrating that the metformin activation of AMPK inhibits the growth of B- and T-cell lymphomas via the inhibition of mTOR signaling, suggesting that metformin can be used in the treatment of lymphoma [193].